Mega Lifesciences (Thailand) Market Value
MEGA Stock | THB 35.25 0.25 0.70% |
Symbol | Mega |
Mega Lifesciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mega Lifesciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mega Lifesciences.
10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in Mega Lifesciences on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding Mega Lifesciences Public or generate 0.0% return on investment in Mega Lifesciences over 30 days. Mega Lifesciences is related to or competes with Chularat Hospital, Ekachai Medical, Bangkok Chain, and Srivichaivejvivat. Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures, markets, and sells health food s... More
Mega Lifesciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mega Lifesciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mega Lifesciences Public upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.13) | |||
Maximum Drawdown | 9.25 | |||
Value At Risk | (2.44) | |||
Potential Upside | 2.68 |
Mega Lifesciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mega Lifesciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mega Lifesciences' standard deviation. In reality, there are many statistical measures that can use Mega Lifesciences historical prices to predict the future Mega Lifesciences' volatility.Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.14) | |||
Total Risk Alpha | (0.32) | |||
Treynor Ratio | (0.32) |
Mega Lifesciences Public Backtested Returns
Mega Lifesciences Public has Sharpe Ratio of -0.0589, which conveys that the firm had a -0.0589% return per unit of risk over the last 3 months. Mega Lifesciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mega Lifesciences' Mean Deviation of 1.19, standard deviation of 1.62, and Risk Adjusted Performance of (0.04) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.34, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Mega Lifesciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Mega Lifesciences is expected to be smaller as well. At this point, Mega Lifesciences Public has a negative expected return of -0.0958%. Please make sure to verify Mega Lifesciences' standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Mega Lifesciences Public performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.38 |
Below average predictability
Mega Lifesciences Public has below average predictability. Overlapping area represents the amount of predictability between Mega Lifesciences time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mega Lifesciences Public price movement. The serial correlation of 0.38 indicates that just about 38.0% of current Mega Lifesciences price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.38 | |
Spearman Rank Test | 0.4 | |
Residual Average | 0.0 | |
Price Variance | 1.16 |
Mega Lifesciences Public lagged returns against current returns
Autocorrelation, which is Mega Lifesciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mega Lifesciences' stock expected returns. We can calculate the autocorrelation of Mega Lifesciences returns to help us make a trade decision. For example, suppose you find that Mega Lifesciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Mega Lifesciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mega Lifesciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mega Lifesciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mega Lifesciences stock over time.
Current vs Lagged Prices |
Timeline |
Mega Lifesciences Lagged Returns
When evaluating Mega Lifesciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mega Lifesciences stock have on its future price. Mega Lifesciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mega Lifesciences autocorrelation shows the relationship between Mega Lifesciences stock current value and its past values and can show if there is a momentum factor associated with investing in Mega Lifesciences Public.
Regressed Prices |
Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Mega Stock
Mega Lifesciences financial ratios help investors to determine whether Mega Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mega with respect to the benefits of owning Mega Lifesciences security.